Early treatment of Parkinson’s disease with cabergoline delays the onset of motor complications. Results of a doubleblind levodopa controlled trial. The PKDS009 Study Group - Rinne, UK; Bracco, F; Chouza, C; Dupont, E; Gershanik, O; Marti Masso, JF (Drugs, 1998)